BC Week In Review | Jan 14, 2013
Company News

Oasmia, Abbott deal

Abbott and Oasmia amended a 2009 deal to give Abbott exclusive commercialization rights to Oasmia's canine oncology compounds Paccal Vet and Doxophos Vet. The deal excludes Japan and the Commonwealth of Independent States (CIS) for...
Items per page:
1 - 1 of 1